Cargando…
Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes
SIMPLE SUMMARY: Germline pharmacogenomic variants impact the toxicity of many cancer treatment drugs. Though testing for pharmacogenomic variants prior to initiating systemic cancer treatment is not routine, the Clinical Pharmacogenetics Implementation Consortium recommends dosing modifications for...
Autores principales: | Hutchcraft, Megan L., Lin, Nan, Zhang, Shulin, Sears, Catherine, Zacholski, Kyle, Belcher, Elizabeth A., Durbin, Eric B., Villano, John L., Cavnar, Michael J., Arnold, Susanne M., Ueland, Frederick R., Kolesar, Jill M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468204/ https://www.ncbi.nlm.nih.gov/pubmed/34572750 http://dx.doi.org/10.3390/cancers13184524 |
Ejemplares similares
-
Real-World Evaluation of a Population Germline Genetic Screening Initiative for Family Medicine Patients
por: Hutchcraft, Megan Leigh, et al.
Publicado: (2022) -
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
por: Hutchcraft, Megan L., et al.
Publicado: (2021) -
Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations
por: Al-Mahayri, Zeina N., et al.
Publicado: (2020) -
Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry
por: Jacob, Aasems, et al.
Publicado: (2021) -
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide
por: Soria-Chacartegui, Paula, et al.
Publicado: (2023)